CytomX Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update

    NEXT STORY
    Translate Bio Announces Third Quarter 2020 Financial Results and Reviews Recent Progress
    PREV STORY
    Merus Announces Financial Results for the Third Quarter and Provides Business Update
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ritter Pharmaceuticals, Inc. Raises $23 Million to Fund Initiation of Its Phase 3 Clinical Program in Lactose Intolerance

    Los Angeles, California,, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ...

    author_avatar
    NASDAQ Market News

    Genmab Announces Data to be Presented at 2018 ASH Annual Meeting

    Media Release Thirty-five total abstracts on Genmab owned and partnered programs scheduled for presentation ...

    author_avatar
    NASDAQ Market News

    Kura Oncology to Present at Deutsche Bank 43rd Annual Health Care Conference

    SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage ...

    author_avatar
    NASDAQ Market News